Quanergy Accelerates a Safe Return to Work with 3D LiDAR Solutions for Social Distancing
28.4.2020 22:19:00 EEST | Business Wire | Press release
Quanergy Systems, Inc., a leading provider of LiDAR (Light Detection and Ranging) sensors and smart perception solutions, today announced the expansion of its Flow Management™ Platform to support solutions that enforce social distancing, regarded by medical experts as the most impactful strategy to halt the spread of COVID-19. These solutions will assist businesses and public entities around the world in returning to work while keeping people safe.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200428005957/en/
3D LiDAR Social Distancing Solutions to Accelerate Safe Return to Work (Photo: Business Wire)
Quanergy’s Flow Management Platform, which combines its state-of-the-art 3D LiDAR sensors with its AI-powered QORTEX™ Perception Software, enables the development of sophisticated social distancing solutions to anonymously and accurately track and analyze the flow of people in real time within retail locations, airports, public venues, commercial and government buildings, and industrial warehouses.
LiDAR uses light to locate and identify objects with a high degree of accuracy in any lighting conditions. Quanergy’s QORTEX Perception Software uses LiDAR data to identify and track individuals throughout an environment without compromising or storing any personal privacy information, unlike camera-based systems. It also does not require user opt-in or the sharing of personal data, thus providing a far more effective social distancing solution than alternatives.
In response to the COVID-19 pandemic and social distancing directives, Quanergy is working with partners to deploy its Flow Management Platform which accurately measures the location of and distance between people, as well as the number of people in a given location to prevent overcrowding. When the distance between individuals is less than the allowed social distance, or the number of people in an area exceeds a given limit, an alert is issued and personnel may be dispatched. When combined with technology such as thermal cameras, the platform identifies individuals with high-body temperatures, helping curb the spread of the virus. Quanergy’s Flow Management™ Platform also accurately counts people entering and exiting common areas, such as conference rooms, to maintain the desired density of people.
“In order for communities and cities to re-open and for the public to feel safe re-entering society, there must be a way to responsibly enforce social distancing,” said Dr. Kevin J. Kennedy, Chairman and CEO of Quanergy. “We believe LiDAR can play a key role in accelerating our return to work and restarting our economy. Quanergy is working closely with our current and new global partners to deploy solutions to instill confidence for businesses and the public in returning to our lives outside our homes.”
The following examples demonstrate the power of Quanergy’s Flow Management™ Platform as a critical tool to enforce social distancing:
- Businesses – Control the maximum number of people in common areas such as conference rooms and break rooms, and maintain social distancing.
- Distribution centers – Guarantee goods delivery while protecting the safety of employees.
- Factories – Restart production by ensuring all employees are not exhibiting signs of the virus before entering facilities, including conducting employee temperature checks.
- Train, Metro stations – Avoid long-queues by replacing turnstiles with contact-less solutions that can accurately keep count of the number of people entering and exiting a station.
- Buses, trains – Ensure safety on public transit during high-traffic commute hours by tracking and reporting maximum people count.
- Retail, airports, public offices – Reduce wait-time in security lines and automatically dispatch cleaning services to specific areas.
Social distancing solutions built upon Quanergy’s Flow Management Platform, will soon be available around the world through Quanergy’s company partners. For instance:
- Quantum Labs, based in Australia, has deployed solutions for high profile, globally recognized sites, airports, intersections and high security facilities that are ideal at providing not only social distance monitoring, but also provide significant enhancements to the ongoing security of the site.
- iCENT, a leading 3D LiDAR-based security and safety platform solution provider in Korea, provides monitoring services through its iSaver technology to predict and prevent human and property damage from safety and security threats at urban and industrial sites and special facilities.
- CRON Systems, an India-based 3D LiDAR solutions provider, integrates data from thermal temperature cameras allowing accurate tracking of individuals in a zone and highlighting threat levels.
- Axone, a French integrated security solution provider, is preparing an offer combining different technologies for people management, including temperature detection with thermal cameras, people counting, people tracking, crowd detection, and analytics.
- iinside, a US based airport motion analytics company, recently released SafeDistance, to monitor and analyzes crowd density in public spaces, such as airports.
"Quanergy delivers the best LiDAR platform for generating the iinside motion analytics used by some of the best and largest US airports to manage passenger congestion. Faced with new social distancing guidelines, this same technology is now being applied to enhance passenger safety," said Sam Kamel, President and CEO of iinside.
As part of our commitment to facilitate a safe return to the work place, Quanergy is offering a complimentary loaner/license program to qualified partners and end users.
To request more information about Quanergy’s Flow Management Platform and use for social distancing applications, please contact our sales team.
About Quanergy Systems, Inc.
Quanergy Systems, Inc. was founded in 2012 and builds on decades of experience of its team in the areas of optics, photonics, optoelectronics, artificial intelligence software, and control systems. Headquartered in Sunnyvale, California, in the heart of Silicon Valley, Quanergy offers a high-performance AI-powered LiDAR platform designed to accelerate the automation of key business processes to increase productivity, efficiency, and safety of our 3D world. By providing actionable insights to organizations across major industries including, mapping, security, smart cities, and smart spaces, industrial automation and transportation, Quanergy is enabling its partners and their end-users to deploy innovative solutions to drive their business growth and ultimately, improve the quality of life for people around the world. For more information, visit www.quanergy.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200428005957/en/
Contact information
Sona Kim
Marketing Communications Manager
408.245.9500
media@quanergy.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 12:47:00 EEST | Press release
Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food products. Within this inspiring premise, Good Food Makers confirms itself as one of the main levers f
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 11:16:00 EEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
